327 related articles for article (PubMed ID: 31727875)
1. Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease.
Kim DK; Han D; Park J; Choi H; Park JC; Cha MY; Woo J; Byun MS; Lee DY; Kim Y; Mook-Jung I
Exp Mol Med; 2019 Nov; 51(11):1-17. PubMed ID: 31727875
[TBL] [Abstract][Full Text] [Related]
2. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
[TBL] [Abstract][Full Text] [Related]
3. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
[TBL] [Abstract][Full Text] [Related]
5. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
[TBL] [Abstract][Full Text] [Related]
6. Temporal and Sex-Linked Protein Expression Dynamics in a Familial Model of Alzheimer's Disease.
Blasco Tavares Pereira Lopes F; Schlatzer D; Wang R; Li X; Feng E; Koyutürk M; Qi X; Chance MR
Mol Cell Proteomics; 2022 Sep; 21(9):100280. PubMed ID: 35944844
[TBL] [Abstract][Full Text] [Related]
7. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology.
Hong I; Kang T; Yoo Y; Park R; Lee J; Lee S; Kim J; Song B; Kim SY; Moon M; Yun KN; Kim JY; Mook-Jung I; Park YM; Choi S
J Alzheimers Dis; 2013; 36(2):321-34. PubMed ID: 23603400
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer's disease mouse models.
Neuner SM; Wilmott LA; Hoffmann BR; Mozhui K; Kaczorowski CC
Behav Brain Res; 2017 Mar; 322(Pt B):288-298. PubMed ID: 27265785
[TBL] [Abstract][Full Text] [Related]
11. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
[TBL] [Abstract][Full Text] [Related]
12. Detection of early proteomic alterations in 5xFAD Alzheimer's disease neonatal mouse model via MALDI-MSI.
Uras I; Karayel-Basar M; Sahin B; Baykal AT
Alzheimers Dement; 2023 Oct; 19(10):4572-4589. PubMed ID: 36934297
[TBL] [Abstract][Full Text] [Related]
13. Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model.
Gurel B; Cansev M; Sevinc C; Kelestemur S; Ocalan B; Cakir A; Aydin S; Kahveci N; Ozansoy M; Taskapilioglu O; Ulus IH; Başar MK; Sahin B; Tuzuner MB; Baykal AT
J Alzheimers Dis; 2018; 61(4):1399-1410. PubMed ID: 29376847
[TBL] [Abstract][Full Text] [Related]
14. Sex-biased hippocampal pathology in the 5XFAD mouse model of Alzheimer's disease: A multi-omic analysis.
Bundy JL; Vied C; Badger C; Nowakowski RS
J Comp Neurol; 2019 Feb; 527(2):462-475. PubMed ID: 30291623
[TBL] [Abstract][Full Text] [Related]
15. Multi-proteomic analyses of 5xFAD mice reveal new molecular signatures of early-stage Alzheimer's disease.
Lee S; Jang KI; Lee H; Jo YS; Kwon D; Park G; Bae S; Kwon YW; Jang JH; Oh YS; Lee C; Yoon JH
Aging Cell; 2024 Jun; 23(6):e14137. PubMed ID: 38436501
[TBL] [Abstract][Full Text] [Related]
16. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
Katsouri L; Georgopoulos S
PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
[TBL] [Abstract][Full Text] [Related]
17. Network-guided analysis of hippocampal proteome identifies novel proteins that colocalize with Aβ in a mice model of early-stage Alzheimer's disease.
Aladeokin AC; Akiyama T; Kimura A; Kimura Y; Takahashi-Jitsuki A; Nakamura H; Makihara H; Masukawa D; Nakabayashi J; Hirano H; Nakamura F; Saito T; Saido T; Goshima Y
Neurobiol Dis; 2019 Dec; 132():104603. PubMed ID: 31494281
[TBL] [Abstract][Full Text] [Related]
18. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
19. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.
Bai B; Vanderwall D; Li Y; Wang X; Poudel S; Wang H; Dey KK; Chen PC; Yang K; Peng J
Mol Neurodegener; 2021 Aug; 16(1):55. PubMed ID: 34384464
[TBL] [Abstract][Full Text] [Related]
20. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer's disease.
Rayaprolu S; Gao T; Xiao H; Ramesha S; Weinstock LD; Shah J; Duong DM; Dammer EB; Webster JA; Lah JJ; Wood LB; Betarbet R; Levey AI; Seyfried NT; Rangaraju S
Mol Neurodegener; 2020 May; 15(1):28. PubMed ID: 32381088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
